InsiderSignal.AI

InsiderSignal.ai

SRRK - Scholar Rock Holding Corp

Insider Sale by Qatanani Mo (CHIEF SCIENTIFIC OFFICER)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

4 days ago, Qatanani Mo, serving as CHIEF SCIENTIFIC OFFICER at Scholar Rock Holding Corp (SRRK), sold 8,484 shares at $47.07 per share, for a total transaction value of $399,351.00. Following this transaction, Qatanani Mo now holds 98,445 shares of SRRK.

This sale represents a 8.00% decrease in Qatanani Mo's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, February 23, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, February 25, 2026, 2 days after the trade was made.

Scholar Rock Holding Corp operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.

Qatanani Mo

CHIEF SCIENTIFIC OFFICER

Mo Qatanani, Ph.D., is the Chief Scientific Officer of Scholar Rock Holding Corporation (NASDAQ: SRRK), a position he has held since January 2024[[1]](https://fintool.com/app/research/companies/SRRK/people/mo-qatanani). He holds a Ph.D. in Molecular and Human Genetics from Baylor College of Medicine and completed a post-doctoral fellowship at the University of Pennsylvania School of Medicine, with a B.Sc. and M.Sc. in Biology from the American University of Beirut[[3]](https://www.biospace.com/scholar-rock-announces-the-addition-of-katie-peng-to-its-board-of-directors-and-promotes-mo-qatanani-ph-d-to-chief-scientific-officer). Qatanani joined Scholar Rock in September 2021 and has led research functions including discovery biology, protein sciences and antibody engineering, nonclinical safety, and translational sciences[[3]](https://www.biospace.com/scholar-rock-announces-the-addition-of-katie-peng-to-its-board-of-directors-and-promotes-mo-qatanani-ph-d-to-chief-scientific-officer). He brings over 15 years of experience in discovery and translational research across neuromuscular and cardiometabolic disease areas, including leadership roles at Dyne Therapeutics where he served as Vice President and Head of Research, as well as research positions at Alexion Pharmaceuticals, Synageva BioPharma, and Merck[[1]](https://fintool.com/app/research/companies/SRRK/people/mo-qatanani)[[3]](https://www.biospace.com/scholar-rock-announces-the-addition-of-katie-peng-to-its-board-of-directors-and-promotes-mo-qatanani-ph-d-to-chief-scientific-officer). As CSO at Scholar Rock, Qatanani has been instrumental in advancing the company's early-stage pipeline, particularly its cardiometabolic programs, during a pivotal growth stage as the company prepares for potential product launches[[3]](https://www.biospace.com/scholar-rock-announces-the-addition-of-katie-peng-to-its-board-of-directors-and-promotes-mo-qatanani-ph-d-to-chief-scientific-officer). His promotion to Chief Scientific Officer recognized his role as a driving force in the research organization and key member of the leadership team[[3]](https://www.biospace.com/scholar-rock-announces-the-addition-of-katie-peng-to-its-board-of-directors-and-promotes-mo-qatanani-ph-d-to-chief-scientific-officer).

View full insider profile →

Trade Price

$47.07

Quantity

8,484

Total Value

$399,351.00

Shares Owned

98,445

Trade Date

Monday, February 23, 2026

4 days ago

SEC Filing Date

Wednesday, February 25, 2026

Filed 2 days after trade

HEALTHCAREBIOTECHNOLOGY

About Scholar Rock Holding Corp

Company Overview

No company information available
View news mentioning SRRK

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/4297751

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime